A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 Plus Standard of Care (SOC) Versus Placebo Plus Standard of Care in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) (E- CELERATE) (NCT05181540) – Trials in Progress

Abstract: Myeloablative conditioning or high-dose therapy followed by autologous hematopoietic [...]

2022-12-14T13:04:54-08:00December 13th, 2022|
Go to Top